Our Mission

Our efforts center around combination therapy and chemoresistance, with the following topics non-genetic mechanisms of chemoresistance and roles of proteostasis in cancer therapeutics.

Yulin Li, MD, PhD
Assistant Professor of Immunotherapy in Oncology, Academic Institute
Assistant Member, Research Institute
Houston Methodist
Weill Cornell Medical College

Dr. Li is a cancer biologist focusing on the mechanisms of therapeutic resistance. Dr. Li finished his medical school at Beijing Medical University and his graduate school at Penn State. He had his postdoctoral training at Stanford University before joining the Research Institute in late 2017.